The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries?

At present, pay for prescription models are insufficient at containing costs and improving access to medicines. Subscription financing through tenders, licensing fees and unrestricted or fixed volumes can benefit stakeholders across the supply chain. Pharmaceutical manufacturers can reduce the need...

Full description

Saved in:

Bibliographic Details
Published in:	Health economics, policy and law policy and law, 2021-04, Vol.16 (2), p.113-123
Main Authors:	Cherla, Avi, Howard, Natasha, Mossialos, Elias
Format:	Article
Language:	English
Subjects:	Access Agreements Asthma Chronic illnesses Competition Consumer behavior Consumers Containment Cost control Diabetes Discounts Drugs Expenditures Fees & charges Financing Forecasting Generic drugs Generic products Health care policy Health economics Hepatitis C Innovations Licenses Licensing Low income groups Marketing Markets Medicine Monopolies Partnerships Patent drugs Patients Perspective Pharmaceutical industry Pharmaceuticals Prices Production costs Purchasing Purchasing power R&D Research & development Savings Subscriptions Supply Treatment methods Tuberculosis
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!